Medplus Health Services to attend Avendus Investor Conference on November 18-19, 2025
Medplus KMP will attend the Avendus Investor Conference in Mumbai on November 18-19, 2025, for physical meetings. No UPSI will be disclosed, and the schedule may change.
This is a standard intimation of an investor meeting, which is a routine corporate communication. It does not contain any immediate material financial or operational news that would significantly impact the stock price.
The announcement is a routine disclosure about an upcoming investor meeting, with no specific positive or negative financial or operational news, and explicitly states no UPSI will be shared.
Medplus Health Services Limited announced that its Key Managerial Personnel (KMP) will attend the Avendus Investor Conference in Mumbai on November 18, 2025, at 03:00 P.M. and November 19, 2025, at 10:00 A.M. The meetings will be physical. The company confirmed that no Unpublished Price Sensitive Information (UPSI) will be disclosed or discussed during these investor meetings. The schedule is subject to change due to exigencies from investors or the company.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.